Safety Shot reports successful product launches and expansion

Published 31/03/2025, 13:38
Safety Shot reports successful product launches and expansion

SCOTTSDALE, Ariz. - Safety Shot, Inc. (NASDAQ:SHOT), a wellness and dietary supplement company trading near its 52-week low of $0.40, has announced a series of business developments that are expected to drive growth in 2025, according to a statement from CEO Jarrett Boon. The company, currently valued at $27.56 million, has seen its recent product launches and strategic partnerships aimed at increasing product distribution and revenue. InvestingPro analysis indicates the company faces significant financial challenges, with a weak overall health score of 0.66.

In November 2023, Safety Shot introduced its Sure Shot product on Amazon, which sold out within hours. This success was mirrored by the launch of their own e-commerce channel in January 2024. Both events underscored strong consumer demand for the company’s health and wellness beverage designed to mitigate the effects of alcohol consumption. The company has achieved impressive revenue growth of 246% in the last twelve months, though InvestingPro data reveals challenges with negative gross profit margins.

The company’s claims are supported by a human clinical trial published on February 26, 2025, in the Journal of Nutrition and Dietary Supplements. The study demonstrated that Safety Shot significantly reduced blood alcohol concentration (BAC) and hangover symptoms compared to a placebo.

Safety Shot has also focused on product innovation, including rebranding to Sure Shot and introducing a 4 oz. package and an On-the-Go Stick Pack in new flavors. These efforts are part of the company’s commitment to improving product taste and variety.

The company’s expansion into grocery and convenience stores has been facilitated through partnerships with retailers like Walmart.com, Albertson’s, Von’s, select 7-11 locations, GoPuff, and KeHe. Furthermore, Safety Shot announced a spin-off of its Caring Brands division, distributing 2 million shares to Safety Shot shareholders.

To protect its innovations, Safety Shot has secured a new patent, positioning the company as a leader in the dietary supplement industry with scientifically backed products.

Looking ahead, Safety Shot is in the process of acquiring Yerbae, a plant-based energy drink company, which is expected to broaden its product offerings and distribution channels. The acquisition is anticipated to be completed by late May/June 2025, subject to shareholder approval. InvestingPro analysis highlights potential risks, as the company’s short-term obligations currently exceed its liquid assets, with a concerning current ratio of 0.27. Discover more insights and 12 additional ProTips about Safety Shot’s financial position with an InvestingPro subscription.

In 2025, the company plans to shift its marketing strategy away from influencer-centric campaigns towards more grassroots, distribution, and partnership-based initiatives. This change reflects a strategic move to align costs with expected revenue improvements from the Yerbae acquisition and a more cost-conscious marketing approach.

The information in this article is based on a press release statement from Safety Shot, Inc.

In other recent news, Safety Shot, Inc. has announced a significant development with the upcoming spin-off of its subsidiary, Caring Brands, Inc. The record date for this spin-off is set for April 7, 2025, and stockholders will receive shares in Caring Brands if they meet the eligibility criteria. Additionally, Safety Shot has entered into a Securities Purchase Agreement for a private investment, securing approximately $1.29 million in funding. This strategic move is intended to support the company’s operational activities and growth initiatives.

Moreover, Safety Shot has released results from a clinical trial demonstrating the effectiveness of its product, Safety Shot®, in reducing alcohol effects, which could bolster its position in the wellness market. The study, published in the Journal of Nutrition and Dietary Supplements, shows promising results in lowering blood alcohol levels and alleviating hangover symptoms. In terms of financial activities, another Securities Purchase Agreement was finalized, securing $1 million in funding, indicating investor confidence in the company’s potential.

These recent developments reflect Safety Shot’s ongoing efforts to strengthen its market position and financial standing. The company’s focus on expanding its product reach and securing investments highlights its strategic initiatives to drive growth and innovation in the competitive personal care and wellness industries.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.